Yaky Yanay
2018
In 2018, Yaky Yanay earned a total compensation of $443.4K as Co, CEO and President at Pluristem Therapeutics, a 87% decrease compared to previous year.
Compensation breakdown
| Salary | $416,740 |
|---|---|
| Other | $26,619 |
| Total | $443,359 |
Yanay received $416.7K in salary, accounting for 94% of the total pay in 2018.
Yanay also received $26.6K in other compensation.
Rankings
In 2018, Yaky Yanay's compensation ranked 12,244th out of 14,244 executives tracked by ExecPay. In other words, Yanay earned more than 14.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 12,244 out of 14,244 | 14th |
Division Manufacturing | 4,956 out of 5,765 | 14th |
Major group Chemicals And Allied Products | 1,873 out of 2,128 | 12th |
Industry group Drugs | 1,602 out of 1,817 | 12th |
Industry Biological Products, Except Diagnostic Substances | 308 out of 339 | 9th |
Source: SEC filing on April 25, 2019.
Yanay's colleagues
We found two more compensation records of executives who worked with Yaky Yanay at Pluristem Therapeutics in 2018.
News
Pluristem Therapeutics CEO Yaky Yanay's 2023 pay jumps 111% to $2.7M
May 1, 2024
Pluristem Therapeutics CEO Yaky Yanay's 2022 pay falls 86% to $1.3M
February 27, 2023
Pluristem Therapeutics Chairman Zami Aberman's 2020 pay falls 54% to $501K
April 8, 2021
Pluristem Therapeutics Chairman Zami Aberman's 2019 pay jumps 85% to $1.1M
May 20, 2020
Pluristem Therapeutics CEO Zami Aberman's 2018 pay falls 83% to $593K
April 25, 2019